- mail us help@24marketresearch.com
- Int'l 1(332) 2424 294 (Int'l)
TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
The United States Lactose-Free Infant Formula market was valued at US$ 1.85 billion in 2024 and is projected to reach US$ 2.95 billion by 2030, at a CAGR of 8.1% during the forecast period 2024-2030.
Specially processed infant formula containing pre-digested lactose or alternative carbohydrates.
Manufacturing spans 18 specialized facilities with 94% capacity utilization. Quality control ensures zero lactose content. Distribution serves 85,000 retail points. Clinical validation supports efficacy claims. Innovation in enzyme technology improved processing by 55%. Clean label products represent 82%. Export markets expanded 48% primarily to Europe. Research partnerships with 38 nutrition institutes. Sustainability initiatives reduced packaging waste by 45%. Direct-to-consumer sales grew 135%. Organic variants increased by 62%.
This report contains market size and forecasts of Lactose-Free Infant Formula in United States, including the following market information:
• United States Lactose-Free Infant Formula Market Revenue, 2019-2024, 2024-2030, ($ millions)
• United States Lactose-Free Infant Formula Market Sales, 2019-2024, 2024-2030,
• United States Top five Lactose-Free Infant Formula companies in 2023 (%)
Report Includes
This report presents an overview of United States market for Lactose-Free Infant Formula , sales, revenue and price. Analyses of the United States market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report focuses on the Lactose-Free Infant Formula sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the United States Lactose-Free Infant Formula market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues.
This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Sales Channels, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Humidifier sales, projected growth trends, production technology, sales channels and end-user industry.
• Milk Infant Formula
• Non-milk Infant Formula
• Premature
• Babies with galactosemia
• Infants with Cow's Milk Protein Allergies
• Other
Key Companies covered in this report:
• Similac (Abbott Laboratories)
• Enfamil (Mead Johnson Nutrition)
• Gerber (Nestl
1.1 Lactose-Free Infant Formula Product Introduction
1.2.1 United Statesn Lactose-Free Infant Formula Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Milk Infant Formula
1.2.3 Non-milk Infant Formula
1.3.1 United States Lactose-Free Infant Formula Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Premature
1.3.3 Babies with galactosemia
1.3.4 Infants with Cow's Milk Protein Allergies
1.3.5 Other
1.4 United States Lactose-Free Infant Formula Sales Estimates and Forecasts 2019-2030
1.5 United States Lactose-Free Infant Formula Hydrocephalus Shunts Revenue Estimates and Forecasts 2019-2030
1.6 Study Objectives
1.7 Years Considered
2.1 United States Lactose-Free Infant Formula Sales by Manufacturers
2.1.1 United States Lactose-Free Infant Formula Sales by Manufacturers (2019-2024)
2.1.2 United States Lactose-Free Infant Formula Sales Market Share by Manufacturers (2019-2024)
2.1.3 Top Largest Manufacturers of Lactose-Free Infant Formula in 2023 in United States
2.2 United States Lactose-Free Infant Formula Revenue by Manufacturers
2.2.1 United States Lactose-Free Infant Formula Revenue by Manufacturers (2019-2024)
2.2.2 United States Lactose-Free Infant Formula Revenue Market Share by Manufacturers (2019-2024)
2.2.3 United States Top Companies by Lactose-Free Infant Formula Revenue in 2023
2.3 United States Lactose-Free Infant Formula Sales Price by Manufacturers (2019-2024)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)
2.4.2 United States Lactose-Free Infant Formula by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 United States Lactose-Free Infant Formula Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3.1 Lactose-Free Infant Formula Market Size by Region: 2019-2030
3.1.1 United States Lactose-Free Infant Formula Sales by Region: 2019-2024
3.1.2 United States Lactose-Free Infant Formula Sales Forecast by Region (2025-2030)
3.1.3 United States Lactose-Free Infant Formula Revenue by Region: 2019-2024
3.1.4 United States Lactose-Free Infant Formula Revenue Forecast by Region (2025-2030)
4.1 United States Lactose-Free Infant Formula Sales by Type
4.1.1 United States Lactose-Free Infant Formula Historical Sales by Type (2019-2024)
4.1.2 United States Lactose-Free Infant Formula Forecasted Sales by Type (2025-2030)
4.1.3 United States Lactose-Free Infant Formula Sales Market Share by Type (2019-2030)
4.2 United States Lactose-Free Infant Formula Revenue by Type
4.2.1 United States Lactose-Free Infant Formula Historical Revenue by Type (2019-2024)
4.2.2 United States Lactose-Free Infant Formula Forecasted Revenue by Type (2025-2030)
4.2.3 United States Lactose-Free Infant Formula Revenue Market Share by Type (2019-2030)
4.3 United States Lactose-Free Infant Formula Price by Type
4.3.1 United States Lactose-Free Infant Formula Price by Type (2019-2024)
4.3.2 United States Lactose-Free Infant Formula Price Forecast by Type (2025-2030)
5.1 United States Lactose-Free Infant Formula Sales by Application
5.1.1 United States Lactose-Free Infant Formula Historical Sales by Application (2019-2024)
5.1.2 United States Lactose-Free Infant Formula Forecasted Sales by Application (2025-2030)
5.1.3 United States Lactose-Free Infant Formula Sales Market Share by Application (2019-2030)
5.2 United States Lactose-Free Infant Formula Revenue by Application
5.2.1 United States Lactose-Free Infant Formula Historical Revenue by Application (2019-2024)
5.2.2 United States Lactose-Free Infant Formula Forecasted Revenue by Application (2025-2030)
5.2.3 United States Lactose-Free Infant Formula Revenue Market Share by Application (2019-2030)
5.3 United States Lactose-Free Infant Formula Price by Application
5.3.1 United States Lactose-Free Infant Formula Price by Application (2019-2024)
5.3.2 United States Lactose-Free Infant Formula Price Forecast by Application (2025-2030)
6.1 Similac (Abbott Laboratories)
6.1.1 Similac (Abbott Laboratories) Corporation Information
6.1.2 Similac (Abbott Laboratories) Overview
6.1.3 Similac (Abbott Laboratories) in United States: Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2019-2024)
6.1.4 Similac (Abbott Laboratories) Lactose-Free Infant Formula Product Introduction
6.1.5 Similac (Abbott Laboratories) Recent Developments
6.2 Enfamil (Mead Johnson Nutrition)
6.2.1 Enfamil (Mead Johnson Nutrition) Corporation Information
6.2.2 Enfamil (Mead Johnson Nutrition) Overview
6.2.3 Enfamil (Mead Johnson Nutrition) in United States: Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2019-2024)
6.2.4 Enfamil (Mead Johnson Nutrition) Lactose-Free Infant Formula Product Introduction
6.2.5 Enfamil (Mead Johnson Nutrition) Recent Developments
6.3 Gerber (Nestl
Frequently Asked Questions ?
